07630.HK
Impact Therap-b
HKSE · Healthcare · Drug Manufacturers - General · CN
HKD 15.59
+4.07%Aug 11, 2026, 15:24 UTC
Impac Pharma issued a profit warning on August 11, 2026, expecting H1 2026 revenue of approximately 94.7 million to 116 million yuan, up 276%-359% year-on-year, and a net loss of 81.7 million to 99.9 million yuan, narrowing 22%-37% from the prior year.
Source: